Tactic Pharma LLC
SEC insider (Form 3/4/5 filer). CIK 0001727357. 10% Owner at Monopar Therapeutics (MNPR). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2025. Located in LAKE FOREST, IL.
Companies Tactic Pharma LLC has filed insider reports for
- Monopar Therapeutics (MNPR): 10% Owner
Tactic Pharma LLC
CIK: 0001727357
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MNPR
Monopar Therapeutics
10% Owner